OrthoPediatrics Corp. Launches 3P™ Pediatric Plating Platform™ Hip System and Completes First Case
OrthoPediatrics (NASDAQ: KIDS) has launched its new 3P™ Pediatric Plating Platform™ Hip System in the United States, successfully completing its first surgical case.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OrthoPediatrics (NASDAQ: KIDS) has launched its new 3P™ Pediatric Plating Platform™ Hip System in the United States, successfully completing its first surgical case. The innovative system is designed to treat proximal femur fractures and deformities in pediatric patients.
The comprehensive system features a Beam Screw construct and Locking Proximal Femur Plates available in Infant, Child, and Adolescent sizes. As part of the Trauma & Deformity Correction product suite, it integrates advanced implant and instrument technology for both trauma and deformity surgeries. Following the launch, more than 10 cases have been booked for August, with expected growth in procedural volume.
Details
News Market Reaction – KIDS
On Aug 1, the day this news came out, KIDS closed 1.59% below the previous close.
Data tracked by StockTitan Argus for the Aug 1 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., Aug. 01, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the US launch and first surgical case of the new 3P™ Pediatric Plating Platform™ Hip System, used to treat proximal femur fractures and deformities.
“The 3P Pediatric Plating Platform Hip System is an exceptional product that would not be possible without our remarkable design surgeons and development teams. By harnessing their insights and leveraging next-generation hardware, this system offers surgeons improved precision with additional fixation options. The demand being placed on implants continues to evolve, by addressing these new unmet needs while building upon this 3rd generation system will improve proximal femur care options,” said OrthoPediatrics Trauma and Deformity and OPSB division President, Joe Hauser commented.
CEO, David Bailey added, “This launch marks our inaugural Pediatric Plating Platform and underscores our commitment to expanding the platform into the most comprehensive plating portfolio in pediatric orthopedics.”
Part of the Trauma & Deformity Correction suite of products, the comprehensive 3P Hip System includes a Beam Screw construct and Locking Proximal Femur Plates available in Infant, Child, and Adolescent sizes. The 3P Hip System integrates advanced implant and instrument technology to support both trauma and deformity surgeries, giving surgeons unmatched precision and a complete array of fixation options for proximal femur procedures. The first surgical case for the 3P Pediatric Plating Platform Hip System utilizing the Beam Screw construct has been completed with overwhelmingly positive feedback. Following the system launch, more than 10 cases were booked in August alone, with procedural volume expected to grow substantially in the coming months.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.